Screening for Type 2 Diabetes Mellitus: A Systematic Review for the U.S. Preventive Services Task Force
The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Screening for type 2 diabetes mellitus could lead to earlier identification and treatment of asymptomatic diabetes, impaired fasting glucose (IFG), or impaired glucose tolerance (IGT), potentially resulting in improved outcomes. PURPOSE: To update the 2008 U.S. Preventive Services Task Force review on diabetes screening in adults. DATA SOURCES: Cochrane databases and MEDLINE (2007 through October 2014) and relevant studies from previous Task Force reviews. STUDY SELECTION: Randomized, controlled trials; controlled, observational studies; and systematic reviews. DATA EXTRACTION: Data were abstracted by 1 investigator and checked by a second; 2 investigators independently assessed study quality. DATA SYNTHESIS: In 2 trials, screening for diabetes was associated with no 10-year mortality benefit versus no screening (hazard ratio, 1.06 [95% CI, 0.90 to 1.25]). Sixteen trials consistently found that treatment of IFG or IGT was associated with delayed progression to diabetes. Most trials of treatment of IFG or IGT found no effects on all-cause or cardiovascular mortality, although lifestyle modification was associated with decreased risk for both outcomes after 23 years in 1 trial. For screen-detected diabetes, 1 trial found no effect of an intensive multifactorial intervention on risk for all-cause or cardiovascular mortality versus standard control. In diabetes that was not specifically screen-detected, 9 systematic reviews found that intensive glucose control did not reduce risk for all-cause or cardiovascular mortality and results for intensive blood pressure control were inconsistent. LIMITATION: The review was restricted to English-language articles, and few studies were conducted in screen-detected populations. CONCLUSION: Screening for diabetes did not improve mortality rates after 10 years of follow-up. More evidence is needed to determine the effectiveness of treatments for screen-detected diabetes. Treatment of IFG or IGT was associated with delayed progression to diabetes. PRIMARY FUNDING SOURCE: Agency for Healthcare Research and Quality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
1 retracted
Hemmingsen, B., Lund, S. S., Gluud, C., Vaag, A., Almdal, T. P., & Wetterslev, J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008143.pub3 · Cited by 203
RetractedMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“Statistical heterogeneity was assessed using the I(2) statistic (26).”
MethodReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 5×
“Chiasson et al, 2002 (51)* Knowler et al, 2002 (7)* Gernstein et al, 2006 (52)* Holman et al, 2010 (28) Ramachandran et al, 2009 (48) M-H overall (I2 = 0.0”
BackgroundInfluentialDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“…incidence of progression to DM. Knowler et al, 2002 (7)* Katula et al, 2013 (88) Kosaka et al, 2005 (8)* Li et al, 2014 (38) Lindahl et al, 2009 (87) Penn et al, 2009 (84) Ramachandran et al, 2006 (10)* Saito et al, 2011 (40) Sakane et al, 2011 (86) Tuomilehto et al, 2001 (9)* D+L overall (I2 = 77”
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,090
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Research works printed but not linked: 4
- Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, 61, 918
- American Diabetes Association, 2015, Diabetes Care, 38, S1
- Van den Donk M, 2013, Diabetologia
- Wu H, 2010, Chin Med J (Engl), 123, 2908
Cited by
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Manne-Goehler, J., Geldsetzer, P., Agoudavi, K., Andall-Brereton, G., Aryal, K. K., Bicaba, B. W., Bovet, P., Brian, G., Dorobantu, M., Gathecha, G., et al. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002751 · Cited by 324
Siu, A. L., & on behalf of the U.S. Preventive Services Task Force* (2015) · Annals of Internal Medicine · doi:10.7326/m15-2345 · Cited by 319
Hemmingsen, B., Gimenez-Perez, G., Mauricio, D., Roqué i Figuls, M., Metzendorf, M.-I., & Richter, B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003054.pub4 · Cited by 316
General health checks in adults for reducing morbidity and mortality from disease
Krogsbøll, L. T., Jørgensen, K. J., & Gøtzsche, P. C. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009009.pub3 · Cited by 202
Toi, P. L., Anothaisintawee, T., Chaikledkaew, U., Briones, J. R., Reutrakul, S., & Thakkinstian, A. (2020) · Nutrients · doi:10.3390/nu12092722 · Cited by 178
Fatty acid overproduction by gut commensal microbiota exacerbates obesity
Takeuchi, T., Kameyama, K., Miyauchi, E., Nakanishi, Y., Kanaya, T., Fujii, T., Kato, T., Sasaki, T., Tachibana, N., Negishi, H., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2022.12.013 · Cited by 178
Overdiagnosis in primary care: framing the problem and finding solutions
Kale, M. S., & Korenstein, D. (2018) · BMJ · doi:10.1136/bmj.k2820 · Cited by 165
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 206
6. Obesity Management for the Treatment of Type 2 Diabetes
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc16-s009 · Cited by 135
Bernabé‐Ortiz, A., Perel, P., Miranda, J. J., & Smeeth, L. L. (2018) · Primary care diabetes · doi:10.1016/j.pcd.2018.07.015 · Cited by 134
Screening for Diabetes and Prediabetes
Duan, D., Kengne, A. P., & Echouffo-Tcheugui, J. B. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.05.002 · Cited by 145
Classification and Diagnosis of Diabetes
GENUTH, S. M., Palmer, J. P., & Nathan, D. M. (2018) · Cited by 112
Best Practices in the Management of Overweight and Obesity
Tchang, B. G., Saunders, K. H., & Igel, L. I. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2020.08.018 · Cited by 91
Screening for type 2 diabetes mellitus
Peer, N., Balakrishna, Y., & Durão, S. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005266.pub2 · Cited by 123
“Whilst two randomised controlled trials (RCTs) found diabetes screening to be associated with higher levels of short-term anxiety and worry, the overall impact was minimal with no clear long-term negative eFects on psychological outcomes (Selph 2015; Sherifali 2013).”
BackgroundResultInfluentialDeFilipp, Z., Duarte, R. F., Snowden, J. A., Majhail, N. S., Greenfield, D. M., Miranda, J. L., Arat, M., Baker, K. S., Burns, L. J., Duncan, C. N., et al. (2017) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.203 · Cited by 84
Prediabetes Diagnosis and Treatment in Primary Care
Mainous, A. G., Tanner, R. J., & Baker, R. (2016) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2016.02.150252 · Cited by 80
All Patients Should Be Screened for Diabetes Before Total Joint Arthroplasty
Shohat, N., Goswami, K., Tarabichi, M., Sterbis, E., Tan, T. L., & Parvizi, J. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.02.047 · Cited by 80
Prediabetes Screening and Treatment in Diabetes Prevention: The Impact of Physician Attitudes
Mainous, A. G., Tanner, R. J., Scuderi, C. B., Porter, M., & Carek, P. J. (2016) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2016.06.160138 · Cited by 74
Risk Factors for Diabetes Mellitus in Chronic Pancreatitis
Pan, J., Xin, L., Wang, D., Liao, Z., Lin, J., Li, B., Du, T., Ye, B., Zou, W., Chen, H., et al. (2016) · Medicine · doi:10.1097/md.0000000000003251 · Cited by 73
Howells, L., Musaddaq, B., McKay, A. J., & Majeed, A. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-013806 · Cited by 83
“As above, one study noted the differential morbidity outcomes among men and women at the 23-year follow-up of the Da Qing study.(39) The authors commented that lower intervention compliance among men may be relevant.”
BackgroundEffect of gestational diabetes mellitus on lipid profile: A systematic review and meta-analysis
Rahnemaei, F. A., Pakzad, R., Amirian, A., Pakzad, I., & Abdi, F. (2021) · Open Medicine · doi:10.1515/med-2021-0408 · Cited by 83
DeFilipp, Z. M., Duarte, R. F., Snowden, J. A., Majhail, N. S., Greenfield, D., López‐Miranda, J., Arat, M., Baker, K. S., Burns, L. J., Duncan, C., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.05.007 · Cited by 65
Prevalence of Prediabetes and Abdominal Obesity Among Healthy-Weight Adults: 18-Year Trend
Mainous, A. G., Tanner, R. J., Jo, A., & Anton, S. D. (2016) · The Annals of Family Medicine · doi:10.1370/afm.1946 · Cited by 71
DeJesus, R. S., Breitkopf, C. R., Rutten, L. J., Jacobson, D. J., Wilson, P. M., & Sauver, J. S. (2017) · Population Health Management · doi:10.1089/pop.2016.0067 · Cited by 61
“9 Hence, the question of where to direct diabetes prevention interventions within this high-risk population group to potentially achieve its optimum effect in risk reduction remains unanswered.”
Menopause, hormone therapy and diabetes
Stuenkel, C. A. (2017) · Climacteric · doi:10.1080/13697137.2016.1267723 · Cited by 63
Gubin, D. G., Nelaeva, A. A., Uzhakova, A. E., Валерьевна, Х. Ю., Cornélissen, G., & Weinert, D. (2017) · Chronobiology International · doi:10.1080/07420528.2017.1347670 · Cited by 57
“…of Cochrane and MEDLINE databases (2007 through October 2014) has shown that screening for diabetes according to the well-established criteria (American Assoc Diabetes, 2010), initially applied in the present study, did not improve mortality rates after 10 years of follow-up (Selph et al., 2015).”
Collaborators, G. 2. E. M. R. D. A. C. K. D. (2017) · International Journal of Public Health · doi:10.1007/s00038-017-1014-1 · Cited by 63
“Although evidence is not strong enough to conclude that early diagnosis of diabetes will increase survival, treatment of impaired glucose tolerance or impaired fasting glucose, as well as lifestyle interventions, is associated with delayed progression to diabetes (Selph et al. 2015a, b).”
BackgroundLiles, E. G., Coronado, G. D., Perrin, N., Harte, A. H., Nungesser, R., Quigley, N. B., Potter, N. T., Weiss, G., Koenig, T. W., & deVos, T. (2016) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2016.12.004 · Cited by 47
Borgnakke, W. S., & Poudel, P. (2021) · Frontiers in Dental Medicine · doi:10.3389/fdmed.2021.709831 · Cited by 60
Diabetes: An Update on the Pandemic and Potential Solutions
Ali, M. K., Siegel, K. R., Chandrasekar, E. K., Tandon, N., Montoya, P. A., Mbanya, J. C., Chan, J. C. N., Zhang, P., & Narayan, K. M. V. (2017) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0518-9_ch12 · Cited by 71
La educación en salud como una importante estrategia de promoción y prevención
Sánchez, L. M. M., Hernández-Sarmiento, J. M., Jaramillo, L. I. J., Villegas-Álzate, J. D., Álvarez-Hernández, L. F., Roldán-Tabares, M. D., Mejía, C. R., Calle-Estrada, M. C., & Ospina-Jiménez, M. C. (2020) · Archivos de Medicina (Manizales) · doi:10.30554/archmed.20.2.3487.2020 · Cited by 222
A prediction nomogram for the 3-year risk of incident diabetes among Chinese adults
Wu, Y., Hu, H., Cai, J., Chen, R., Zuo, X., Cheng, H. W., & Yan, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-78716-1 · Cited by 44
Firouzi, S. A., Tucker, L. A., LeCheminant, J. D., & Bailey, B. W. (2018) · Journal of Diabetes Research · doi:10.1155/2018/3604108 · Cited by 41
“Obesity, a primary risk factor for type 2 diabetes, affects a significant portion of the United States population [5].”
BackgroundInfluentialEffects of methyl mercury exposure on pancreatic beta cell development and function
Schumacher, L., & Abbott, L. C. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3381 · Cited by 41
Hydrogen Sulfide and Glucose Homeostasis: A Tale of Sweet and the Stink
Untereiner, A. A., & Wu, L. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7046 · Cited by 43
“I n a healthy individual , blood glucose level is strictly regulated in the physiological range of 70–110 mg/dL under prolonged fasting conditions or intensive physical exercise, and * 140 mg/dL postprandially (1, 103, 119).”
Effect of Parachute Jump in the Psychophysiological Response of Soldiers in Urban Combat
Sánchez-Molina, J., Robles‐Pérez, J. J., & Clemente‐Suárez, V. J. (2017) · Journal of Medical Systems · doi:10.1007/s10916-017-0749-9 · Cited by 39
Jonas, D. E., Ferrari, R. M., Wines, R., Vuong, K. T., Cotter, A., & Harris, R. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.08.033 · Cited by 53
Time to question the NHS diabetes prevention programme
Barry, E., Roberts, S. A., Finer, S., Vijayaraghavan, S., & Greenhalgh, T. (2015) · BMJ · doi:10.1136/bmj.h4717 · Cited by 39
Evolución de la mortalidad por diabetes mellitus en España: análisis del periodo 1998-2013
Orozco‐Beltrán, D., Sánchez, E., Garrido, A., Quesada, J. A., Carratalá‐Munuera, C., & Gil-Guillén, V. F. (2016) · Revista Española de Cardiología · doi:10.1016/j.recesp.2016.07.007 · Cited by 35
Blood Glucose Determination: Effect of Tube Additives
(2018) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2017.12.003 · Cited by 28
Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2018
Cuixart, C. B., Sánchez, J. J. A., Banegas, J. R., León, C. F., Lobos-Bejarano, J. M., Rioboó, E. M., Pérez, J. N., Orozco‐Beltrán, D., & Álvarez, F. V. (2018) · Atención Primaria · doi:10.1016/s0212-6567(18)30360-3 · Cited by 49
Machine Learning for Predicting the 3-Year Risk of Incident Diabetes in Chinese Adults
Wu, Y., Hu, H., Cai, J., Chen, R., Zuo, X., Cheng, H., & Yan, D. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.626331 · Cited by 28
“Evidence showed that XGBoost’s performance was significantly better than traditional statistical methods (24, 55, 56).”
MethodScreening for Prediabetes and Type 2 Diabetes Mellitus
Laiteerapong, N., & Cifu, A. S. (2016) · JAMA · doi:10.1001/jama.2015.17545 · Cited by 32
Performance of a Random Glucose Case-Finding Strategy to Detect Undiagnosed Diabetes
Bowen, M. E., Xuan, L., Lingvay, I., & Halm, E. A. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.01.023 · Cited by 36
Rokhman, M. R., Arifin, B., Zulkarnain, Z., Satibi, S., Perwitasari, D. A., Boersma, C., Postma, M. J., & van der Schans, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269853 · Cited by 37
Kullgren, J. T., Knaus, M., Jenkins, K. R., & Heisler, M. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000212 · Cited by 25
Yoon, S., Wee, S. S. H., Loh, D. H. F., Bee, Y. M., & Thumboo, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.816385 · Cited by 29
Low Grip Strength and Prediabetes in Normal-Weight Adults
Mainous, A. G., Tanner, R. J., Anton, S. D., & Jo, A. (2016) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2016.02.150262 · Cited by 27
Trends in Mortality From Diabetes Mellitus in Spain: 1998-2013
Orozco‐Beltrán, D., Sánchez, E., Garrido, A., Quesada, J. A., Carratalá‐Munuera, C., & Gil-Guillén, V. F. (2016) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2016.09.022 · Cited by 25
Glurich, I., Bartkowiak, B., Berg, R. L., & Acharya, A. (2018) · International Dental Journal · doi:10.1111/idj.12405 · Cited by 26
Burrus, M. T., Diduch, D. R., & Werner, B. C. (2018) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-16-00929 · Cited by 22
Wells, B. J., Lenoir, K. M., Diaz‐Garelli, F., Futrell, W. M., Lockerman, E., Pantalone, K. M., & Kattan, M. W. (2018) · JMIR Medical Informatics · doi:10.2196/10780 · Cited by 24
Okada, A., Hashimoto, Y., Goto, T., Yamaguchi, S., Ono, S., Kurakawa, K. I., Nangaku, M., Yamauchi, T., Yasunaga, H., & Kadowaki, T. (2022) · Diabetes Care · doi:10.2337/dc21-1841 · Cited by 25
Undiagnosing to prevent overprescribing
Page, A. T., & Etherton‐Beer, C. (2019) · Maturitas · doi:10.1016/j.maturitas.2019.02.010 · Cited by 27
Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in Kayseri, Turkey
Atayoğlu, A. T., İnanç, N., Başmısırlı, E., & Çapar, A. G. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.01.002 · Cited by 25
Jiranek, W. A., Kigera, J. W. M., Klatt, B. A., Küçükdurmaz, F., Lieberman, J. R., Moser, C. E., Mulhall, K. J., Nahouli, H., Schwarz, E. M., Shohat, N., et al. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.09.052 · Cited by 23
Incidence and Risk Factors for Progression to Diabetes Mellitus: A Retrospective Cohort Study
Hyun, M. K., Park, J. H., Kim, K. H., Ahn, S., & Ji, S. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19010123 · Cited by 27
Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2020
Orozco‐Beltrán, D., Cuixart, C. B., Sánchez, J. J. A., Banegas, J. R., Cuenca, A. M. C., Gil-Guillén, V. F., Rioboó, E. M., & Pérez, J. N. (2020) · Atención Primaria · doi:10.1016/j.aprim.2020.08.002 · Cited by 31
“En un metaanálisis, las intervenciones multifactoria-les frente al control estándar mostraron una reducción del ictus no fatal (RR: 0,53; IC del 95%, 0,32-0,87), pero no de infarto de miocardio no fatal (RR: 0,66; IC del 95%, 0,38-1,03), de mortalidad CV (RR: 0,72; IC del 95%, 0,46-1”
Yuan, Y., Xie, H., Sun, L., Wang, B., Zhang, L., Han, H., Yao, R., Sun, Y., & Fu, L. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s238224 · Cited by 19
Evidence Tips the Scale Toward Screening for Hyperglycemia
Narayan, K. M. V., & Gujral, U. P. (2015) · Diabetes Care · doi:10.2337/dc15-0856 · Cited by 18
A nomogram model for predicting 5-year risk of prediabetes in Chinese adults
Hu, Y., Han, Y. Y., Liu, Y., Cui, Y., Ni, Z., Wei, L., Cao, C., Hu, H., & He, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-50122-3 · Cited by 22
Palladino, R., Vamos, E. P., Chang, K., Khunti, K., Majeed, A., & Millett, C. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-58033-3 · Cited by 20
Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2022
Orozco‐Beltrán, D., Cuixart, C. B., Banegas, J. R., Gil-Guillén, V. F., Cuenca, A. M. C., Rioboó, E. M., Baldó, A. J., Vicuña, J., & Pérez, J. N. (2022) · Atención Primaria · doi:10.1016/j.aprim.2022.102444 · Cited by 80
Glutathione S-transferases gene polymorphism influence on the age of diabetes type 2 onset
Klusek, J. E., Błońska-Sikora, E. M., Witczak, B., Orlewska, K., Klusek, J., Głuszek, S., & Orlewska, E. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001773 · Cited by 16
Heaton, C. M., Vyas, S. G., & Singh, G. (2016) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqw026 · Cited by 15
Jørgensen, P., Langhammer, A., Krokstad, S., & Forsmo, S. (2017) · BMC Family Practice · doi:10.1186/s12875-017-0672-7 · Cited by 17
Rodríguez, L. A., Bradshaw, P. T., SHIBOSKI, S. C., Fernández, A., Vittinghoff, E., Herrington, D. M., Ding, J., & Kanaya, A. M. (2020) · Diabetic Medicine · doi:10.1111/dme.14377 · Cited by 15
Nguyen, B., Lin, K. W., & Mishori, R. (2018) · Public health reviews · doi:10.1186/s40985-018-0095-6 · Cited by 16
Kim, J., Yang, H.-L., Kim, S. H., Kim, S., Lee, J., Ryu, J., Kim, K., Kim, Z., Ahn, G., Kwon, D., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102445 · Cited by 17
Association Between IL-10 Gene Polymorphism and Diabetic Retinopathy
Dong, H., Li, Q., Wang, M., & Wan, G. (2015) · Medical Science Monitor · doi:10.12659/msm.894371 · Cited by 13
“Diabetes mellitus patients account for more than 90% of DR cases in the developed countries such as the USA, its incidence increased yearly because of the continuous improvement of living standards and economics in China, with a serious threat to life and health [1,2].”
BackgroundAssociation Between Number of Preventive Care Guidelines and Preventive Care Utilization by Patients
Taksler, G. B., Pfoh, E. R., Stange, K. C., & Rothberg, M. B. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.03.011 · Cited by 16
Ayensa-Vazquez, J. A., Leiva, A., Tauler, P., López‐González, Á. A., Aguiló, A., Salvá, M. T., & Bennasar‐Veny, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051546 · Cited by 15
Clinical Aspects of Glucose Metabolism and Chronic Disease
Culberson, J. W. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.011 · Cited by 15
Screening strategies for adults with type 2 diabetes mellitus: a systematic review protocol
Mearns, H., Kuodi, P., Shelton, M., Kredo, T., Kagina, B. M. N., & Schmidt, B. (2020) · Systematic Reviews · doi:10.1186/s13643-020-01417-3 · Cited by 15
Shono, A., Kondo, M., Hoshi, S., Okubo, R., & Yahagi, N. (2018) · Diabetes Care · doi:10.2337/dc17-1307 · Cited by 14
Brunisholz, K. D., Conroy, M. B., Belnap, T. W., Joy, E. A., & Srivastava, R. (2020) · Journal for Healthcare Quality · doi:10.1097/jhq.0000000000000281 · Cited by 12
Takakado, M., Takata, Y., Yamagata, F., Yaguchi, M., Hiasa, G., Sato, S., Funada, J., Kawazu, S., & Osawa, H. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000984 · Cited by 10
Screening for Hyperglycemia: The Gateway to Diabetes Prevention and Management for All Americans
Narayan, K. M. V., & Weber, M. B. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0798 · Cited by 13
Exploring in-vivo infrared spectroscopy for nail-based diabetes screening
Lazaro‐Pacheco, D., Taday, P. F., & Paldánius, P. M. (2024) · Biomedical Optics Express · doi:10.1364/boe.520102 · Cited by 12
“However, screening for T2DM may not directly lower mortality rates over a decade of follow-up [3,8]; however, this evidence was based on the accuracy of the conventional methods in a primarily White Caucasian (male) population only.”
BackgroundMethodExenatide Treatment Alone Improves β-Cell Function in a Canine Model of Pre-Diabetes
Ionut, V., Woolcott, O. O., Mkrtchyan, H., Stefanovski, D., Kabir, M., Iyer, M. S., Liu, H., Castro, A. V., Wu, Q., Broussard, J. L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158703 · Cited by 26
Henjum, S., Hjellset, V. T., Andersen, E., Flaaten, M. Ø., & Morseth, M. S. (2022) · BMC Public Health · doi:10.1186/s12889-022-13007-0 · Cited by 10
“Tight control of blood glucose levels significantly reduces the risk of complications [6], and early diagnosis to prevent adverse health outcomes is essential [1].”
BackgroundDiabetes screening intervals based on risk stratification
Ohde, S., McFadden, E. C., Deshpande, G. A., Yokomichi, H., Takahashi, O., Fukui, T., Perera, R., & Yamagata, Z. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0139-1 · Cited by 10
Screening for Diabetes and Prediabetes
Gray, L. J., Willis, A. M., Webb, D. R., Davies, M. J., & Khunti, K. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_12 · Cited by 9
Development of a prediction model to target screening for high blood pressure in children
Hamoen, M., Welten, M., Nieboer, D., Bai, G., Heymans, M. W., Twisk, J. W. R., Raat, H., Vergouwe, Y., Wijga, A. H., & de Kroon, M. L. A. (2020) · Preventive Medicine · doi:10.1016/j.ypmed.2020.105997 · Cited by 10
Doan, L., Nguyen, H. T., Nguyen, T. T., Phan, T. T. L., Huy, L. Đ., Nguyen, T. T. H., & Phuoc, T. D. (2023) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s398455 · Cited by 8
“Moreover, timely screening for identifying individuals with undiagnosed T2DM is the key to diagnosing diabetes at the early stages and preventing T2DM complications.(6) Thus, the validated diabetes risk scoring models, which are defined as “an objective assessment of the probability of the presence or future developme…”
BackgroundGlucosuria and all-cause mortality among general screening participants
Check”, F. T. “. O. T. C. H. C. S. F. C. K. D. (. B. O. T. I. R. A. B. S. H., Iseki, K., Konta, T., Asahi, K., Yamagata, K., Fujimoto, S., Tsuruya, K., Narita, I., Kasahara, M., Shibagaki, Y., et al. (2018) · Clinical and Experimental Nephrology · doi:10.1007/s10157-017-1528-0 · Cited by 9
EZSCAN for undiagnosed type 2 diabetes mellitus: A systematic review and meta-analysis
Bernabé‐Ortiz, A., Ruíz-Alejos, A., Miranda, J. J., Mathur, R., Perel, P., & Smeeth, L. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187297 · Cited by 8
Recomendaciones preventivas vasculares. Actualización PAPPS 2024
Orozco‐Beltrán, D., Brotons-Cuixart, C., Banegas, J. R., Gil-Guillén, V. F., Cuenca, A. M. C., Martín-Rioboó, E., Jordá-Baldó, A., Vicuña, J., & Navarro-Pérez, J. (2024) · Atención Primaria · doi:10.1016/j.aprim.2024.103123 · Cited by 13
Al-Atta, D. M., Al-Samarraee, M. F., Fadhil, A. A., Kadhim, S. T., & Alsarhan, H. W. (2025) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v8i2.1929 · Cited by 6
Primary Care Endocrinology in the Adult Woman
Thomas, C. C., & Zeytinoglu, M. (2016) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2016.01.005 · Cited by 4
Cos, X., Gómez‐Huelgas, R., & Peralta, F. G. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01188-7 · Cited by 5
Jeyaseeli, A., Ganesan, R., Mathivanan, D., & Allen Prabagaran, P. (2023) · Cureus · doi:10.7759/cureus.41880 · Cited by 5
Biancalana, E., Parolini, F., Mengozzi, A., & Solini, A. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00555-x · Cited by 5
Kim, Y. H., Her, A., Jeong, M. H., Kim, B., Hong, S., Kim, S., Ahn, C., Kim, J., Ko, Y., Choi, D., et al. (2020) · Coronary Artery Disease · doi:10.1097/mca.0000000000000969 · Cited by 5
The Role of H2S in the Metabolism of Glucose and Lipids
Sun, H., Wu, Z., Nie, X.-W., & Bian, J. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-0991-6_3 · Cited by 5
Saif-Ali, R., Al-Hamodi, Z. H., Salem, S. D., Al‐Habori, M., Al‐Dubai, S. A. R., & Ismail, I. S. (2024) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_209_23 · Cited by 4
Barton, J. C., Barton, J. C., Adams, P. C., & Acton, R. T. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000278 · Cited by 4
Savić, S., Stanivuković, S., & Lakić, B. (2020) · Medicinski Glasnik · doi:10.17392/1189-20 · Cited by 5
Controversies surrounding percutaneous coronary intervention in the diabetic patient
Martinez, S. C., & Holmes, D. R. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2016.1148600 · Cited by 6
Metadata
- Authors
- Selph, S., Dana, T., Blazina, I., Bougatsos, C., Patel, H., & Chou, R.
- Affiliations
- Oregon Health & Science University (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2015-06-02
- Volume
- 162
- Issue
- 11
- Pages
- 765-776
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2086557545
- Semantic Scholar
- 71271d7cc0522ec02fb4af61d3f48ff903988f34
- Cited by
- 134
- References
- 89
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 8 · 2023: 13 · 2022: 7 · 2021: 12 · 2020: 24 · 2019: 3 · 2018: 19 · 2017: 12 · 2016: 23 · 2015: 8
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (HHSA 290-2007-10057-I)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, diabetes screening, impaired fasting glucose, impaired glucose tolerance, screen-detected diabetes, progression to diabetes, lifestyle modification, tight glycemic control, intensive blood pressure control, cardiovascular mortality, all-cause mortality, USPSTF recommendations
- MeSH terms
- Adult, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Fasting, Humans, Life Style, Mass Screening, United States, Glucose Intolerance, Disease Progression, Risk Assessment, Early Diagnosis, Asymptomatic Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.